bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.
View Top Employees from bioSyntagmaWebsite | http://www.biosyntagma.com |
Revenue | $8 million |
Employees | 3 (2 on RocketReach) |
Founded | 2015 |
Address | 275 N. Gateway Drive Suite 124, Phoenix, Arizona 85034, US |
Phone | (602) 824-8283 |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Social/Platform Software, Biomarker Discovery, Business Services, Science and Engineering, Other Devices and Supplies, Expression Analysis, Life Science, Data Visualization, Pharmaceutical Research, Artificial Intelligence, Spatial 'Omics |
Competitors | BioFluidica, Inc., DiaCarta, Inc., Eutropics, Notable |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular bioSyntagma employee's phone or email?
The bioSyntagma annual revenue was $8 million in 2024.
Colleen Ziegler is the Co Founder; Director of Operations of bioSyntagma.
2 people are employed at bioSyntagma.
bioSyntagma is based in Phoenix, Arizona.
The NAICS codes for bioSyntagma are [541, 54, 541713, 54171, 5417].
The SIC codes for bioSyntagma are [87, 873].